openPR Logo
Press release

Infectious Disease and Molecular Diagnostics Conference | 21st - 22nd March 2024 | Millennium Gloucester Hotel, London

02-13-2024 02:35 PM CET | Health & Medicine

Press release from: ReportsnReports

Infectious Disease and Molecular Diagnostics Conference | 21st

The healthcare sector is undergoing significant transformations, largely due to advancements in technology, and the Diagnostics field has emerged as a pivotal catalyst in this evolution. Given its crucial role in treatment decisions, diagnostics must strive for speed, precision, and accuracy.

We are pleased to announce the 5th Annual Infectious Disease Diagnostics and Molecular Diagnostics Conference, organized by MarketsandMarkets. This esteemed event is scheduled to take place on the 21st and 22nd of March 2024 in London. The conference has been handcrafted to showcase the latest insights in diagnostics, explore emerging technologies and their applications, address challenges within the diagnostics domain, including diagnostic settings, sample processing, regulations, validations, high costs of advanced technologies, challenges related to blood transfusion technology, and the global need for improved healthcare. It will also delve into topics such as vaccine efficacy, side effects, issues with test kits, and the importance of result accuracy.

Enquire Now @

This conference promises to attract an impressive gathering of influential healthcare and industry leaders who are shaping the future of the field. Their expertise and vision make them some of the brightest minds on the planet.

Key Highlights:

Key Sessions on Molecular Diagnostics:
• Developing a Molecular and Rapid Testing Diagnostic Service
• The Impact of NGS in Diagnostic Virology Involving HIV-1 Tropism, Genotypic Resistance in Influenza, HBV, Hepatitis C Virus (HCV) and Cytomegalovirus (CMV)
• Current Molecular Diagnostics and Whole Genome Sequencing (WGS) Applied to Mycobacteria
• KCL TEST: Matching Results from the ONS and Generating Molecular Biology Laboratory-Based Protocols
• Molecular Diagnosis of Drug-Resistant Tuberculosis

Key Sessions on Infectious Diseases:
• Clinical Validation of a Point-of-Care Multiplexed In Vitro Immunoassay Using Monoclonal Antibodies
• The Impact of Digital Technologies on Point-of-Care Diagnostics in Resource-Limited Settings.
• The Challenges and Some Emerging Strategies for Tackling a Global Bacterial Menace
• Biosensors for the Detection of Bacterial and Viral Clinical Pathogens
• Electrochemical Diagnostics of Infectious Viral Diseases

Register Now @

Why Attend?
Stay Updated: The conference provides a platform to gain insights into the latest advancements, trends, and innovations in infectious disease diagnostics and molecular diagnostics.

Networking Opportunities: With 120+ professionals attending the conference provides an excellent opportunity to network, forge valuable connections, and collaborate with like-minded individuals who share a passion for diagnostics and healthcare.

Knowledge Exchange: The conference features discussions, presentations, and interactive sessions led by industry experts and thought leaders.

Emerging Technologies: The conference focuses on trending technologies in diagnostics and their applications. By attending, you can gain insights into emerging tools, platforms, and methodologies that can enhance diagnostic accuracy, speed, and precision.

Address Challenges: The conference addresses challenges faced in the diagnostics field. By participating, you can learn about potential solutions and best practices to overcome these hurdles in the diagnostics world.

Global Healthcare Perspectives: The conference examines the need for improved healthcare worldwide and explores how diagnostics can contribute to this goal. You can gain a broader understanding of the global healthcare landscape and discover ways to facilitate better healthcare outcomes on a global scale.

Vaccine Insights: The event also covers topics related to vaccine efficacy, side effects, and their impact on diagnostics.

Who Should Attend?

Hospitals - Department of infectious diseases. Department of hematology, Department of Genomics, Diagnostics Department, Molecular Biology, Molecular Genetics

Hospital Designations - Senior scientist, scientist, Microbiologist, biologists, pathologist, General
Practitioners, Lab managers, Lab directors, medical directors, POCT coordinators

Universities Designations- Professors, Researchers, Associate professors, Deans, Senior Professors
Hospital Laboratories Designations- Pathologists, Lab managers, Lab Directors, Clinicians

Pharma/Therapeutics Designation- CEO, COO, Senior scientist, Research scientist, POCT specialist

Become a Speaker @

Magarpatta City, Hadapsar, Pune, India - 411013

About Us:-
MarketsandMarkets Conferences, a leading international event organizer since 2014, takes pride in organizing over 200 conferences globally. With our extensive experience and rich legacy, we bring together experts from around the world to drive knowledge sharing and innovation in the healthcare and lifesciences sectors.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Infectious Disease and Molecular Diagnostics Conference | 21st - 22nd March 2024 | Millennium Gloucester Hotel, London here

News-ID: 3383136 • Views:

More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact! Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices. Register Now @ MarketsandMarkets presents
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Conference Promises New Trends and Insights in Diagnosis
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH. This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March 2024| Challenges and Factors affecting in Sterilization of medical devices and more
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays. Enquire Now @ This conference aims to bring together all the stakeholders to discuss the obstacles in achieving
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, Surface and Forecast to 2025
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying

All 5 Releases

More Releases for Diagnostic

Tenet Diagnostic: Reshaping the Diagnostic Industry in India
Tenet Diagnostic was incorporated in 2018 with an aim to establish high-quality diagnostics laboratories across India. The company caters to both B2B and B2C. They have seven different verticals namely: End Customer (B2C), Lab to Lab Test Outsourcing, Corporates and Institutions, large management (Hospitals, Medical Colleges, and other healthcare institutions), Clinical Trials, Home Sample Collection, and Government PPP Projects. Tenet Diagnostics got its NABL certification in the fastest time and is
Global Tissue Diagnostic Market 2020 Business Strategies – Roche Diagnostic, A …
The Zion Market Research added a new report “Tissue Diagnostic Market by Product Type (Consumables and Instruments), by Technology (Immunohistochemistry (IHC), in Situ Hybridization (ISH), Digital Pathology and Workflow Management, and Special Staining), by Diseases (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC), and Others), and by End-users (Hospitals, Research Laboratories, Ambulatory Surgical Centers, Diagnostic Centers, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017
Diagnostic Imaging Services Market 2019 Analyzed by Top Key Players PH3 Healthca …
Big Market Research has added a report, titled, "Diagnostic Imaging Services" The report not only provides a comprehensive analysis of market overview and dynamics for the historical period, 2019-2026, but also offers global and regional forecasts on market value, volume production, and consumption during the future period, 2019-2026. The report also analyzes the key market players, especially the distributors, along with the industrial chain structure. The evolution of market trends
POC Cardiovascular Diagnostic Market Report 2018: Segmentation by Product (Diagn …
Global POC Cardiovascular Diagnostic market research report provides company profile for F. Hoffmann-La Roche, Siemens, Abbott, Biomerieux, Danaher and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation on
Cervical Dysplasia Diagnostic Market - by Diagnostic, and End Users
Cervical infection is major risk factor for progression of HPV. Currently, conventional Pap smear test or HPV test are the only test available for screening cervical infection, which in turn propels the demand for development of DNA-based molecular testing to detect human papillomavirus for diagnosis of cervical cancer. For instance, in 2016, Becton, Dickinson and Company received pre-diagnostic market approval from FDA for its Onclarity HPV assay, type of HPV
Diagnostic Imaging Services Market Trending Technologies and Company Overview 20 …
Diagnostic Imaging Services market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market. The report includes the forecasts, Analysis and discussion of important industry trends, market size, market share estimates and profiles of the